EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers

Diabetic foot ulcers are a major cause of morbidity and amputation. This randomized controlled trial will compare the efficacy of a traditional antiseptic dressing (EUSOL) with a modern biologic dressing containing Platelet-Derived Growth Factor (PDGF) in promoting wound contraction. The study aims to determine if PDGF dressing leads to better healing outcomes in patients with Grade II Wagner diabetic foot ulcers.

NCT Number	NCT07493343
Lead Sponsor	Services Hospital, Lahore Collaborators: Services Institute of Medical Sciences, Pakistan
Conditions	Diabetic Wound
Enrollment	120 participants
Start Date	2020-01-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-01-10 (estimated)
Updated on ClinicalTrials.gov	2026-03-25